ReviewJournal of translational medicine2025
Liver regeneration: unraveling the molecular mechanisms and clinical application.
Review in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Cell Sheet Technology as a Platform for Functional Regeneration.International journal of molecular sciences · 2026Review
- How Physiology and Pharmacology Shape Liver Regeneration: From Molecules and Cells to Trials.International journal of molecular sciences · 2026Review
- Endothelial Cell Therapy for the Acute and Chronic Liver Disease.Seminars in liver disease · 2026Review
- Photoacoustic Tomography Tracks Vascular Remodeling and Functional Recovery in Liver Regeneration.BME frontiers · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The liver's exceptional capacity sets it apart from other organs in its response to various acute and chronic injuries, known as "liver regeneration". Liver regeneration is not driven by a single pathway, but is achieved through a multi-level network including hepatocyte dedifferentiation, liver progenitor cell (LPCs)activation, non-coding RNA regulation, and metabolic reprogramming. Moreover, liver regeneration research still faces challenges: precise regulation of regeneration termination signals, the tumorigenic risk of stem cell therapy, and immune rejection in personalized treatment, among other issues, need to be addressed urgently. In this review, we delineate the cellular dynamics of liver regeneration and synthesize numerous signaling pathways and factors that prominently contribute to liver regeneration alongside recent research advancements. As well as its current clinical application including molecular therapy, stem cell therapy, and the development of artificial livers. We also discuss some of the current problems and look forward to new treatments. By integrating findings from numerous studies, it provides a comprehensive understanding of liver regeneration, highlighting its significance in treating liver diseases and guiding future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.